{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:03:20Z","timestamp":1776146600836,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer, France","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"name":"GIRCI SOHO"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41768-w","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:15:37Z","timestamp":1772781337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of patients diagnosed for acute myeloid leukemia before and during the 2020 COVID-19 pandemic: the DATAML population-based cohort"],"prefix":"10.1038","volume":"16","author":[{"given":"S\u00e9bastien","family":"Lamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00ebl","family":"Fenni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Tavitian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9opoldine","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaut","family":"Leguay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Galtier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Sarry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Charlotte","family":"De-Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Berard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Pigneux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"R\u00e9cher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"41768_CR1","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1200\/GO.20.00423","volume":"6","author":"AR Jazieh","year":"2020","unstructured":"Jazieh, A. R. et al. Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars. JCO global Oncol. 6, 1461\u20131471 (2020).","journal-title":"JCO global Oncol."},{"key":"41768_CR2","doi-asserted-by":"crossref","unstructured":"Zaniboni, A. et al. A review of clinical practice guidelines and treatment recommendations for cancer care in the COVID-19 pandemic. Cancers (Basel) 12(9), 2452 (2020).","DOI":"10.3390\/cancers12092452"},{"key":"41768_CR3","doi-asserted-by":"crossref","unstructured":"Brissot, E. et al. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transpl. 56, 532\u2013535 (2021).","DOI":"10.1038\/s41409-020-0970-x"},{"issue":"2","key":"41768_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.htct.2020.04.001","volume":"42","author":"M Garnica","year":"2020","unstructured":"Garnica, M. & Maiolino, A. COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionals. Hematol. Transfus. Cell. Therapy. 42 (2), 111\u2013112 (2020).","journal-title":"Hematol. Transfus. Cell. Therapy"},{"key":"41768_CR5","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3389\/fonc.2020.01689","volume":"10","author":"L Wilde","year":"2020","unstructured":"Wilde, L., Isidori, A., Keiffer, G., Palmisiano, N. & Kasner, M. Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience. Front. Oncol. 10, 1689 (2020).","journal-title":"Front. Oncol."},{"issue":"6","key":"41768_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bulcan.2020.04.002","volume":"107","author":"M Delaye","year":"2020","unstructured":"Delaye, M., Naoun, N. & Mailly-Giacchetti, L. [SARS-CoV-2 and cancer in France: Resident in oncology on the front line. Testimony of residents in oncology in two French clusters: Grand-Est and \u00cele-de-France]. Bull. Cancer. 107 (6), 633\u2013637 (2020).","journal-title":"Bull. Cancer"},{"issue":"3","key":"41768_CR7","doi-asserted-by":"publisher","first-page":"100134","DOI":"10.1016\/j.esmoop.2021.100134","volume":"6","author":"JY Blay","year":"2021","unstructured":"Blay, J. Y. et al. Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France. ESMO open. 6 (3), 100134 (2021).","journal-title":"ESMO open."},{"key":"41768_CR8","doi-asserted-by":"crossref","unstructured":"Grosclaude, P. et al. COVID-19 impact on the cancer care structuration: example of the multidisciplinary team meeting dedicated to oncology in Occitanie. Bull. Cancer 107(7\u20138), 730\u2013737 (2020).","DOI":"10.1016\/j.bulcan.2020.05.001"},{"key":"41768_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2021.05.012","volume":"153","author":"A Bardet","year":"2021","unstructured":"Bardet, A. et al. Impact of COVID-19 on healthcare organisation and cancer outcomes. Eur. J. Cancer. 153, 123\u2013132 (2021).","journal-title":"Eur. J. Cancer"},{"key":"41768_CR10","doi-asserted-by":"publisher","first-page":"106518","DOI":"10.1016\/j.leukres.2021.106518","volume":"101","author":"F Mart\u00edn-Moro","year":"2021","unstructured":"Mart\u00edn-Moro, F. et al. The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid. Leuk. Res. 101, 106518 (2021).","journal-title":"Leuk. Res."},{"issue":"11","key":"41768_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jech-2011-200311","volume":"66","author":"C Pornet","year":"2012","unstructured":"Pornet, C. et al. Construction of an adaptable European transnational ecological deprivation index: the French version. J. Epidemiol. Community Health. 66 (11), 982\u2013989 (2012).","journal-title":"J. Epidemiol. Community Health"},{"key":"41768_CR12","doi-asserted-by":"publisher","first-page":"102522","DOI":"10.1016\/j.canep.2024.102522","volume":"89","author":"A Quillet","year":"2024","unstructured":"Quillet, A., Le Stang, N., Meriau, N., Isambert, N. & Defossez, G. Socio-demographic inequalities in stage at diagnosis of lung cancer: A French population-based study. Cancer Epidemiol. 89, 102522 (2024).","journal-title":"Cancer Epidemiol."},{"issue":"6","key":"41768_CR13","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/ijc.31951","volume":"144","author":"L Tron","year":"2019","unstructured":"Tron, L. et al. Socioeconomic environment and disparities in cancer survival for 19 solid tumor sites: An analysis of the French Network of Cancer Registries (FRANCIM) data. Int. J. Cancer. 144 (6), 1262\u20131274 (2019).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"41768_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1186\/s12885-019-6093-3","volume":"19","author":"E Berger","year":"2019","unstructured":"Berger, E. et al. Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients. BMC Cancer. 19 (1), 883 (2019).","journal-title":"BMC Cancer"},{"key":"41768_CR15","doi-asserted-by":"crossref","unstructured":"Fianu, A. et al. Health impacts of the COVID-19 lockdown measure in a low socio-economic setting: A cross-sectional study on Reunion Island. Int. J. Environ. Res. Public. Health 19(21), 13932 (2022).","DOI":"10.3390\/ijerph192113932"},{"issue":"1","key":"41768_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s43856-025-01214-w","volume":"5","author":"S Sma\u00efli","year":"2025","unstructured":"Sma\u00efli, S. et al. Dynamics of social inequalities in severe COVID-19 outcomes in metropolitan France from 2020 to 2022. Commun. Med. 5 (1), 516 (2025).","journal-title":"Commun. Med."},{"key":"41768_CR17","unstructured":"Bouyer, J. \u00c9pid\u00e9miologie: principes et m\u00e9thodes quantitatives (Tec & Doc Lavoisier, 2009)."},{"issue":"11","key":"41768_CR18","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1080\/10428194.2022.2087065","volume":"63","author":"A Tedjaseputra","year":"2022","unstructured":"Tedjaseputra, A. et al. Hyperleukocytosis associated with delayed presentation among patients with acute leukemia during the COVID-19 pandemic. Leuk. Lymphoma. 63 (11), 2731\u20132734 (2022).","journal-title":"Leuk. Lymphoma"},{"key":"41768_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1200\/GO.20.00620","volume":"7","author":"R Demichelis-G\u00f3mez","year":"2021","unstructured":"Demichelis-G\u00f3mez, R. et al. Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries. JCO global Oncol. 7, 577\u2013584 (2021).","journal-title":"JCO global Oncol."},{"issue":"Supplement 1","key":"41768_CR20","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1182\/blood-2021-147979","volume":"138","author":"C Chen","year":"2021","unstructured":"Chen, C., Rotter, D., Kiendrebeogo, Z. & Potluri, R. The Impact of COVID-19 on Acute Myeloid Leukemia (AML) Treatment Patterns in the United States: Retrospective Analysis of an Electronic Medical Records (EMR) Database. Blood 138 (Supplement 1), 4139 (2021).","journal-title":"Blood"},{"issue":"1","key":"41768_CR21","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1186\/s12889-022-13537-7","volume":"22","author":"R Darques","year":"2022","unstructured":"Darques, R., Trottier, J., Gaudin, R. & Ait-Mouheb, N. Clustering and mapping the first COVID-19 outbreak in France. BMC Public. Health. 22 (1), 1279 (2022).","journal-title":"BMC Public. Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41768-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41768-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41768-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:23:02Z","timestamp":1776144182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41768-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41768"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41768-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare the following conflict of interest : PYD declares a consulting or advisory role with Daiichi-Sankyo, Jazz Pharmaceutical, Astellas, Abbvie, Celgene, Janssen, BMS, Gilead, Novartis, and Servier. CR declares a consulting or advisory role with Abbvie, Amgen, Astellas, BMS, Boehringer, Jazz Pharmaceuticals and Servier, and received research funding from Abbvie, Amgen, Astellas, BMS, Iqvia and Jazz Pharmaceuticals. SB declares a consulting or advisory role with Abbvie, Astellas, BMS-Celgene, Jazz Pharmaceuticals and Servier.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The cohort has been approved by the national ethical authorities (CCTIRS (ref 15.319) and CNIL (ref 915285)).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients included in the DATAML cohort received and signed the information notice to express their non-opposition for the use of their data for research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patients consent"}}],"article-number":"12336"}}